Back to News
Market Impact: 0.2
Immunocore reports third quarter financial results and provides a business update
Source: globenewswire.com
Corporate EarningsHealthcare & BiotechCompany Fundamentals
KIMMTRAK (tebentafusp-tebn) generated net revenues of $102.2 million in Q3 2026 and $324.8 million in the first nine months of 2026. Year-to-date net revenues grew 10% year over year.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Further turmoil could be in store for tech stocks. What to watch in the week ahead
- Elon Musk once said the Cybertruck would be Tesla’s ‘best product ever.’ Now he’s winding down production
- AI stocks hammered by midterm shock as data center buildout becomes a 'war of attrition'
- Fox completes its $22B acquisition of Roku
- Elanco Shares Jump After Q3 Beat and Outlook Raise
- FTSE 100 today: Stocks slump as global tech rout deepens